breseq  version 0.35.4  revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Predicted mutations
evidence position mutation annotation gene description
RA 874,860 G→A M221I (ATG→ATA yliI → aldose sugar dehydrogenase YliI
RA 1,431,900 G→A Q1048* (CAG→TAG)  nifJ ← pyruvate:ferredoxin (flavodoxin) oxidoreductase
RA 3,332,267 G→T S114* (TCG→TAG)  mlaE ← lipid asymmetry maintenance ABC transporter permease subunit MlaE
RA 3,794,325 T→G M1M (ATG→CTG) † rfaY ← lipopolysaccharide core heptose(II) kinase RfaY
RA 4,175,791 T→G F172V (TTC→GTC)  rpoC → DNA‑directed RNA polymerase subunit beta'
RA 4,323,524 C→T D82N (GAT→AAT)  basR ← two‑component system response regulator BasR

Unassigned missing coverage evidence
   seq id start end size ←reads reads→ gene description
* * ÷ NZ_CP009273 3416728 3417884–3417022 295–1157 86 [85] [85] 87 rrf–[BW25113_RS16985] rrf,BW25113_RS16975,rrf,[BW25113_RS16985]

Unassigned new junction evidence
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? NZ_CP009273 = 341670789 (0.610)12 (0.360)
+191 bp
12/114 2.7 37.1% intergenic (+154/+77) yhdZ/rrf amino acid ABC transporter ATP‑binding protein/5S ribosomal RNA
?NZ_CP009273 3416716 = 88 (0.600)intergenic (+163/+68) yhdZ/rrf amino acid ABC transporter ATP‑binding protein/5S ribosomal RNA